Biotech Values

[Summer2762]

Thank you.

In a related development (Apologies if this was posted here before)

U.S. FDA Grants Priority Review Of ZYTIGA® (Abiraterone Acetate) sNDA For Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy

http://www.jnj.com/connect/news/all/us-fda-grants-priority-review-of-zytiga-abiraterone-acetate-snda-for-treatment-of-metastatic-castration-resistant-prostate-cancer-before-chemotherapy

Let's see if this will get approved in 3 months as well (this NDA was submitted in June 2012 and it is a supplemental NDA).